Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the relevant provisions of the SEBI Listing Regulations, we would like to inform you that the officials of our Company, Supriya Lifescience Limited ('Company') will be interacting with Analyst/Institutional Investors on June 22, 2023 via in person meeting. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby enclose the transcript of the Earnings call held on Monday, May 29, 2023 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23).
Buy Supriya Lifesciences; target of Rs 292: KR Choksey
KR Choksey is bullish on Supriya Lifesciences has recommended buy rating on the stock with a target price of Rs 292 in its research report dated May 31, 2023. Supriya Lifescience Ltd - 543434 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Regulation 24A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, we enclosed herewith Annual Secretarial Compliance Report dated May 30, 2023 issued by M/s. DSM & Associates, Practicing Company Secretary, for the financial year ended March 31, 2023. Supriya Lifescience Ltd - 543434 - Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015
We refer to your email dated May 25, 2023 regarding Additional Details Required for Corporate Announcement filed on May 24, 2023 at 12:24:10 P.M. under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. We are hereby furnishing the additional details required under SEBI Circular dated 9th September, 2015, for Corporate Announcement filed on May 24, 2023 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Supriya Lifescience Ltd - 543434 - Audio Recording Of Earnings Call
In accordance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company''s Earnings Call held today (i.e., May 29, 2023) regarding discussion on operational and financial performance for the Fourth Quarter and Year ended of FY 2022-2023 (Q4 & FY23) is available on the Company''s website. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Newspaper Publication
With reference to the above captioned subject, please find enclosed newspaper advertisement published in Financial Express and Loksatta on Saturday, May 27, 2023, containing extract of Audited Financial Results for the quarter and year ended March 31, 2023. Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Investor Presentation
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the Investor Presentation. Supriya Lifescience Ltd - 543434 - Statement Of Deviation Or Variation In The Use Of Proceeds Of The Fresh Issue Of The Initial Public Offer Of The Company
Pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please find enclosed herewith statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended March 31, 2023 in the prescribed format. Further, we hereby confirm that there is no deviation or variation in the utilisation of IPO proceeds from the objects stated in the prospectus dated December 21, 2021. Supriya Lifescience Ltd - 543434 - Disclosure Of Related Party Transactions Pursuant To Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosure of Related Party Transactions for the half year ended March 31, 2023.